Hospital de Sant Pau

Futó vizsgálatok

• Még nem toboroz

  A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

  NCT07335562· 3. fázis· Forrás

• Még nem toboroz

  A study to learn how dapirolizumab pegol transfers to babies from pregnant mothers with active systemic lupus erythematosus

  2025-524595-37-00· 1. fázis· Forrás

• Toboroz

  Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease

  NCT07781657· 2. fázis· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  2024-518365-10-00· 3. fázis· Forrás

• Még nem toboroz

  A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)

  2026-525755-82-00· 3. fázis· Forrás

• Még nem toboroz

  A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)

  2026-525757-37-00· 3. fázis· Forrás

• Még nem toboroz

  A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis

  NCT07873801· 3. fázis· Forrás

• Toboroz

  Evaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  2025-523288-39-00· 2. fázis· Forrás

• Toboroz

  Phase 3 Study of Azenosertib Versus Chemotherapy in Platinum-Resistant Ovarian Cancers Positive for Cyclin E1 Protein Expression

  2025-524641-27-00· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

  NCT07541170· 3. fázis· Forrás

• Toboroz

  A TWO-STAGE, SINGLE-ARM, PHASE II STUDY OF ZONGERTINIB PLUS FULVESTRANT IN PARTICIPANTS WITH HORMONE RECEPTOR-POSITIVE/HER2- NEGATIVE ADVANCED BREAST CANCER HARBORING HER2 MUTATIONS (AGATHA)

  2026-525328-10-00· 2. fázis· Forrás

• Toboroz

  A Phase 3 Study Comparing Ramantamig plus Daratumumab Versus DVRd or DRd in Participants With NDMM for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

  2026-526654-14-01· 3. fázis· Forrás

• Toboroz

  A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tumour location (right-PTL) - ARIEL-ENGIC 04 EU trial

  2025-521209-42-00· 4. fázis· Forrás

• Toboroz

  Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)

  2026-525489-23-00· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· Forrás

• Még nem toboroz

  Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)

  NCT07247786· 2. fázis· Forrás

• Toboroz

  Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)

  NCT07711002· 3. fázis· Forrás

• Még nem toboroz

  A phase II clinical trial of inotuzumab ozogamicin as prophylaxis for relapse in patients with lymphoblastic leukaemia after allogeneic stem cell haemotopoietic transplantation

  2026-525964-17-00· 2. fázis· Forrás

• Toboroz

  A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT07680764· 2. fázis· Forrás

• Toboroz

  A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not Planned

  NCT07665450· 3. fázis· Forrás

• Még nem toboroz

  A study to learn about the effects of Trontinemab in participants at risk for Alzheimer‘s disease

  2025-524314-29-00· 3. fázis· Forrás

• Még nem toboroz

  Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer

  NCT07717099· 2. fázis· Forrás

• Még nem toboroz

  iSGLT2 in permanent atrial fibrillation, heart failure with preserved ejection fraction and intermediate NT-proBNP values: randomized clinical trial

  2026-525968-18-00· 4. fázis· Forrás

• Még nem toboroz

  Multicentre, randomized, open label study comparing the concomitant administration of trabectedin and low-dose radiotherapy versus trabectedin alone in patients with advanced sarcoma

  2026-525703-27-00· 4. fázis· Forrás

• Még nem toboroz

  Rollover Study for Participants Who Have Completed a Previous Clinical Study with Anifrolumab (Saphnelo) and Clinically Benefited from Continued Treatment.

  2026-526419-13-00· 3. fázis· Forrás

• Toboroz

  Phase 2 Randomized, Double-blind, Placebo-controlled Study of Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma

  2025-524793-42-00· 2. fázis· Forrás

• Toboroz

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  NCT07737743· 2. fázis· Forrás

• Toboroz

  A Phase Ib/II Study to Evaluate Safety and Efficacy of Bexmarilimab in Combination With Doxorubicin in Metastatic Soft-tissue Sarcoma.

  NCT07460986· 1/2. fázis· Forrás

• Toboroz

  ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

  NCT06716021· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)

  NCT07636811· 2. fázis· Forrás

• Még nem toboroz

  Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer.

  2026-525883-17-00· 3. fázis· Forrás

• Toboroz

  A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder

  NCT07775300· 3. fázis· Forrás

• Toboroz

  A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes

  2025-524688-19-00· 3. fázis· Forrás

• Toboroz

  BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

  NCT07625644· 3. fázis· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Forrás

• Toboroz

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

  NCT07659782· 2. fázis· Forrás

• Toboroz

  A study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflammation in adult participants with moderately to severely active rheumatoid arthritis.

  2025-522076-85-00· 2. fázis· Forrás

• Toboroz

  Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

  NCT07621809· 3. fázis· Forrás

• Toboroz

  ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

  NCT07673627· 2. fázis· Forrás

• Toboroz

  Pridopidine Phase 3 Study in Huntington's Disease

  NCT07609108· 3. fázis· Forrás

• Még nem toboroz

  Evaluation of Calcified Coronary Lesion Preparation With the Naviscore Scoring Balloon

  NCT07650578· Forrás

• Még nem toboroz

  Optimizing the Use of Aspirin for the Prevention of Preeclampsia

  NCT07665853· 3. fázis· Forrás

• Toboroz

  A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07589634· 2. fázis· Forrás

• Toboroz

  A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer

  2025-522818-23-00· 3. fázis· Forrás

• Toboroz

  A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  NCT07650916· 3. fázis· Forrás

• Fut, nem toboroz

  A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small cell lung cancer.

  2023-503298-39-00· 3. fázis· Forrás

• Toboroz

  Grass Immunotherapy for Rhinitis and Asthma (GIRA)

  2025-521736-10-00· 3. fázis· Forrás

• Toboroz

  Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy

  NCT07902791· 3. fázis· Forrás

• Toboroz

  Brain imaging to understand early changes in dementia related diseases

  2025-523284-37-00· 2. fázis· Forrás

• Toboroz

  Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  NCT07504458· 3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák43 toboroz
• Prosztatarák20 toboroz
• Gyermekkori daganatok13 toboroz
• Hólyagrák12 toboroz
• Vastagbélrák12 toboroz
• Szarkóma11 toboroz
• Szívelégtelenség11 toboroz
• Akut mieloid leukémia (AML)10 toboroz
• Alzheimer-kór9 toboroz
• Krónikus limfoid leukémia (CLL)9 toboroz
• Lupus (SLE)9 toboroz
• Mielóma multiplex9 toboroz
• Myasthenia gravis9 toboroz
• Pitvarfibrilláció9 toboroz
• Stroke (szélütés)9 toboroz
• Parkinson-kór7 toboroz
• Zsírmáj (MASLD/MASH)7 toboroz
• Epilepszia6 toboroz
• Fej-nyaki daganatok6 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)6 toboroz
• Szisztémás szklerózis (szkleroderma)6 toboroz
• Vesedaganat6 toboroz
• Depresszió5 toboroz
• Hasnyálmirigyrák5 toboroz
• Huntington-kór5 toboroz
• Koszorúér-betegség5 toboroz
• Asztma4 toboroz
• Elhízás4 toboroz
• Gyomor- és nyelőcsőrák4 toboroz
• Melanóma4 toboroz
• Pikkelysömör4 toboroz
• Rheumatoid arthritis4 toboroz
• 1-es típusú cukorbetegség3 toboroz
• Áttétes emlőrák3 toboroz
• HIV-fertőzés3 toboroz
• Méhtestrák3 toboroz
• Petefészekrák3 toboroz
• Sjögren-szindróma3 toboroz
• Akut limfoid leukémia (ALL)2 toboroz
• Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
• Follikuláris limfóma2 toboroz
• Hipertrófiás kardiomiopátia2 toboroz
• Köpenysejtes limfóma2 toboroz
• Máj- és epeúti rák2 toboroz
• Méhnyakrák2 toboroz
• Mieloproliferatív neopláziák2 toboroz
• Sarlósejtes vérszegénység2 toboroz
• Skizofrénia2 toboroz
• Tripla negatív emlőrák2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Amiloidózis1 toboroz
• Arthritis psoriatica1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Diabéteszes retinopátia1 toboroz
• Endometriózis1 toboroz
• Frontotemporális demencia1 toboroz
• Hemofília1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Hodgkin-limfóma1 toboroz
• Időskori makuladegeneráció1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Mielodiszplasztikus szindróma (MDS)1 toboroz
• Migrén1 toboroz
• Neuroendokrin daganatok1 toboroz
• Sclerosis multiplex (SM)1 toboroz
• Spondylitis ankylopoetica (Bechterew-kór)1 toboroz
• Thalassaemia1 toboroz
• Zöldhályog (glaukóma)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Clinical trial in multiple hospitals to explore new ways to diagnose and monitor tuberculosis treatment

  2025-522235-34-00· 4. fázis· Forrás

• Fut, nem toboroz

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

  NCT07234942· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease

  NCT07246941· 1. fázis· Forrás

• Lezárult

  C4971006: A Study to Learn About the Effects of 2 Study Medicines (Maplirpacept [PF-07901801] and Glofitamab) When Given Together in People With Relapsed or Refractory Diffuse Large B Cell Lymphoma

  NCT05896163· 1/2. fázis· Forrás

• Lezárult

  Safety, Tolerability, and Efficacy of NVG-2089 in Participants with CIDP

  2024-515386-34-00· 2. fázis· Forrás

• Lezárult

  A trial to learn how well benralizumab works and how safe it is when given in addition to standard asthma treatments in people with eosinophilic asthma

  2024-515162-13-00· 3. fázis· Forrás

• Lezárult

  A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of MK-1167 as Adjunctive Therapy in Participants with Mild to Moderate Alzheimer’s Disease Dementia

  2024-515539-31-00· 2. fázis· Forrás

• Fut, nem toboroz

  Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

  NCT06726265· 3. fázis· Forrás

• Lezárult

  An Open Label Clinical Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adult Patients with Focal Onset or Primary Generalized Tonic-Clonic Seizures

  2024-517061-16-01· 2. fázis· Forrás

• Lezárult

  A RANDOMIZED PHASE I, DOUBLE-BLIND, PARALLEL, COMPARATIVE ASSESSMENT OF PHARMACOKINETICS, SAFETY, PHARMACODYNAMICS, AND IMMUNOGENICITY OF LT-01 (AN OMALIZUMAB BIOSIMILAR CANDIDATE [TEST]) LYOPHYLIZED POWDER FOR SUBCUTANEOUS INJECTION VERSUS EU-APPROVED XOLAIR® LYOPHYLIZED POWDER FOR SUBCUTANEOUS INJECTION (REFERENCE) IN HEALTHY SUBJETCS: CIMA STUDY.

  2023-505908-28-00· 1. fázis· Forrás

• Lezárult

  Hero: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of ION269 in Participants With Down Syndrome (DS) at Risk for Alzheimer’s Disease (AD)

  2023-509257-31-00· 1. fázis· Forrás

• Lezárult

  A study to compare effects and safety of CT-P51 and Keytruda in patients with previously untreated metastatic lung cancer

  2024-514048-98-00· 3. fázis· Forrás

• Fut, nem toboroz

  Immunotherapy Consolidation After Radical Treatment of Synchronous Oligo-metastatic NSCLC

  NCT06219317· 2. fázis· Forrás

• Fut, nem toboroz

  A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

  NCT06593522· 2. fázis· Forrás

• Lezárult

  Study to evaluate food effect on the pharmacokinetics of mesalazine oral formulation in healthy volunteers.

  2024-514748-10-00· 1. fázis· Forrás

• Lezárult

  A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1)

  2024-514559-13-00· 2/3. fázis· Forrás

• Lezárult

  A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and an Open- labeled Long-term Extension Treatment with Aticaprant

  2024-511557-21-00· 3. fázis· Forrás

• Lezárult

  A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart in Participants with Sjögren’s Disease

  2024-512986-15-00· 2. fázis· Forrás

• Fut, nem toboroz

  To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

  NCT06553027· 3. fázis· Forrás

• Lezárult

  Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

  NCT06667414· Forrás

• Lezárult

  A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

  NCT06588738· 3. fázis· Forrás

• Lezárult

  Effects of maintenance cabozantinib+BSC versus BSC in children and AYA with osteosarcoma. ( CabOSTar )

  NCT06341712· 2. fázis· Forrás

• Fut, nem toboroz

  Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.

  NCT06359002· 1. fázis· Forrás

• Lezárult

  A Study designed to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered in participants with PD-L1 ≥ 1% TC Stage IIB, IIIA, or select IIIB (T3N2 only) NSCLC following resection and adjuvant platinum-based chemotherapy

  2023-506696-10-00· 3. fázis· Forrás

• Lezárult

  A clinical study comparing different doses of a potential new medicine with an inactive medicine for patients with moderate to severe psoriasis

  2023-508992-35-00· 2. fázis· Forrás

• Lezárult

  Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure

  NCT06418932· Forrás

• Lezárult

  A Pharmacokinetics (PK) study to compare GME751 (proposed pembrolizumab biosimilar) and United States (US)-licensed and European Union (EU)-approved Keytruda®in participants with stage Ⅱ and Ⅲ skin cancer requiring adjuvant treatment (therapy applied after initial treatment of cancer to suppress the regrowth of tumor) with pembrolizumab.

  2023-506881-30-00· 1. fázis· Forrás

• Lezárult

  A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

  NCT06238817· 3. fázis· Forrás

• Lezárult

  A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

  NCT05813288· 3. fázis· Forrás

• Lezárult

  Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

  NCT06119217· 2. fázis· Forrás

• Lezárult

  A clinical study for patients with newly diagnosed, locally advanced non-small cell lung cancer (NSCLC) with a change in the ALK-gene, to test the effect of brigatinib after standard chemotherapy and radiation therapy is completed.

  NCT05718297· 2. fázis· Forrás

• Lezárult

  A study to investigate the effect of different doses of AZD0780 on low-density lipoprotein cholesterol (LDL-C) levels compared with placebo and its safety and tolerability in participants 18 to 75 years of age with dyslipidemia

  2023-506197-12-00· 2. fázis· Forrás

• Lezárult

  VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1

  NCT06214052· 2. fázis· Forrás

• Lezárult

  A phase IIa, open label, single centre study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of orally dosed MBF-015 in Huntington's disease patients

  2023-505241-10-00· 2. fázis· Forrás

• Leállították

  Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML

  NCT06268574· 2. fázis· Forrás

• Lezárult

  A Multicenter, Open-Label Clinical Trial of RVU120 in Patients with Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia with or without NPM1 Mutation (RIVER-52)

  2023-505910-10-00· 2. fázis· Forrás

• Lezárult

  Multicenter Phase 2 study to evaluate the efficacy and safety of Cetuximab in combination with Encorafenib plus Binimetinib as induction treatment in BRAF (V600E) mutated MSS, initially resectable or potentially resectable advanced colorectal cancer: CEBBRA study.

  2022-502413-29-00· 2. fázis· Forrás

• Lezárult

  RANDOMIZED, CONTROLLED, OPEN, MULTICENTRIC CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A COMBINATION OF ANTI-TUBERCULOUS DRUGS BASED ON HIGH DOSE RIFAMPICIN, HIGH DOSE MOXIFLOXACIN AND LINEZOLID IN PATIENTS WITH BACILLIFEROUS PULMONARY TUBERCULOSIS (RML-TB).

  2023-509075-17-00· 2. fázis· Forrás

• Fut, nem toboroz

  A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment

  NCT06105632· 2. fázis· Forrás

• Lezárult

  A Dose Escalation and Cohort Expansion Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors or Non-Hodgkin Lymphoma.

  NCT04718675· 1. fázis· Forrás

• Leállították

  IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack

  NCT06139328· 2. fázis· Forrás

• Lezárult

  CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).

  NCT05797792· 3. fázis· Forrás

• Lezárult

  CHemical OptImization of Cerebral Embolectomy in patients with acute stroke treated with mechanical thrombectomy 2 (CHOICE2TRIAL)

  2023-504262-32-01· 3. fázis· Forrás

• Leállították

  IMM60 and Pembrolizumab in Melanoma and NSCLC

  NCT05709821· 1/2. fázis· Forrás

• Lezárult

  A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

  NCT06108544· 3. fázis· Forrás

• Lezárult

  A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

  NCT06073119· 2. fázis· Forrás

• Lezárult

  A Phase 3, Double-blind Maintenance Study Assessing Rocatinlimab in Moderate-to-severe AD (ROCKET-ASCEND)

  NCT05882877· 3. fázis· Forrás

• Leállították

  A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer

  NCT05983367· 2. fázis· Forrás

• Lezárult

  A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

  NCT05848011· 2. fázis· Forrás

• Lezárult

  A study to investigate response to ompenaclid combined with FOLFIRI plus bevacizumab in patients with advanced or metastatic colorectal cancer

  2023-503356-27-00· 2. fázis· Forrás

Vizsgálati helyszínek

• 7240050 - Hospital de la Santa Creu i Sant Pau1 vizsgálat
• Hopital Sant Pau1 vizsgálat
• Hosp. de La Santa Creu I Sant Pau9 vizsgálat
• Hospital de la Santa Creu i de Sant Pau4 vizsgálat
• Hospital de la Santa Creu i Sant Pau709 vizsgálat
• Hospital de la Santa Creu i Sant Pau Barcelona1 vizsgálat
• Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona 080411 vizsgálat
• Hospital de la Santa Creu i Sant Pau - Dept of Oncology2 vizsgálat
• Hospital de La Santa Creu i Sant Pau - Dermatologia0 vizsgálat
• Hospital de la Santa Creu i Sant Pau /ID# 2796420 vizsgálat
• Hospital de la Santa Creu i Sant Pau Servicio de Dermatologia0 vizsgálat
• HOSPITAL DE LA SANTA CREU I SANT PAU - Servicio de Hematología1 vizsgálat
• Hospital de la Santa Creu i Sant Pau (Site 0385)0 vizsgálat
• Hospital de la Santa Creu I Sant Pau Site #13040 vizsgálat
• Hospital de la Santa Creu i Sant Pau (Site 1807)0 vizsgálat
• Hospital de la Santa Creu i Sant Pau, Unidad de trastornos del movimiento1 vizsgálat
• Hospital de la Santa Creu i Sant Pau, Unitat de Diabetis, Servei d'Endocrinologia i Nutrició, Universitat Autònoma de Barcelona0 vizsgálat
• Hospital del la Santa Creu i Sant Pau1 vizsgálat
• Hospital de Santa Creu I Sant Pau1 vizsgálat
• Hospital de Sant Pau5 vizsgálat
• Hospital de Sant Pau i de la Santa Creu1 vizsgálat
• Hospital De Sant Pau I La Santa Creu1 vizsgálat
• Hospital Santa Creu i Sant Pau14 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 1142-05351 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 1249631 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 1531930 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 1541251 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2013250 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2147140 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2154291 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2258130 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2298590 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2318211 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2385011 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2485111 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2572941 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2604980 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2626370 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2713110 vizsgálat
• Hospital Santa Creu i Sant Pau /ID# 2763191 vizsgálat
• Hospital Santa Creu i Sant Pau (Site 0241)1 vizsgálat
• Hospital Santa Creu i Sant Pau (Site 1501)1 vizsgálat
• Hospital Santa Creu i Sant Pau (Site 4102)0 vizsgálat
• Hospital Sant Pau4 vizsgálat
• Hospital Sant Pau Barcelona0 vizsgálat
• Hospital Sant Pau i la Santa Creu (Site 0905)0 vizsgálat
• Neurology (Memory Unit) - Hospital de la Santa Creu i Sant Pau1 vizsgálat
• Sant Pau Hospital0 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Alzheimer-kór260 munka · 29 vizsgálat
• Pikkelysömör38 munka · 19 vizsgálat
• Szarkóma32 munka · 23 vizsgálat
• Crohn-betegség23 munka · 1 vizsgálat
• Huntington-kór20 munka · 13 vizsgálat
• Myasthenia gravis19 munka · 15 vizsgálat
• Frontotemporális demencia14 munka · 2 vizsgálat
• Lewy-testes demencia14 munka · 0 vizsgálat
• Szisztémás szklerózis (szkleroderma)13 munka · 17 vizsgálat
• Pompe-betegség9 munka · 1 vizsgálat
• Duchenne-izomdisztrófia7 munka · 0 vizsgálat
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)3 munka · 10 vizsgálat